Fortrea Holdings Inc (FTRE)

Fortrea Holdings Inc. is a Nasdaq-listed common stock company that operates as a contract research organization serving pharmaceutical, biotechnology, and medical device customers worldwide. The company supports biopharmaceutical product and medical device development through a broad set of clinical and advisory capabilities. Its services include clinical pharmacology work such as clinical research unit support, external partnerships, study design, project management, bioanalytics, biomarkers, pharmacokinetics, modeling and simulation, and biometrics. Fortrea also provides clinical development services across phases I to IV and real-world evidence studies, along with regulatory affairs, protocol development, site start-up, patient recruitment, monitoring, data management, biostatistics, pharmacovigilance, medical writing, and mobile clinical services. In addition, it offers consulting in product development and regulatory matters, market access and health economics, outcomes research, and real-world evidence services. The company was incorporated in 2023 and is headquartered in Durham, North Carolina.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.